Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award

A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.

Sarah Gilbert awarded 2023 King Faisal Prize

Professor Dame Sarah Gilbert, the Saïd Chair of Vaccinology in the Nuffield Department of Medicine has been selected to receive King Faisal Prize for Medicine for 2023, along with Professor Dan Barouch of Harvard Medical School.

Exclusive interview with Professor Miles Carroll

Here at VaccineNation we are delighted to kickstart the new year with another one of our recorded interviews from the World Vaccine Congress in Europe. As we look forward to the Congress in Washington in April, we will be releasing further interviews and exploring key themes for the event. For this interview we were lucky to secure a slot with Professor Miles Carroll of Oxford University. A specialist in high consequence emerging viral infections, his insight into how we respond to new threats and prepare for the future is incredibly exciting!

'Meet the man preparing Britain for the next pandemic'

Article from The Telegraph (14.12.22) about Professor Peter Horby and his plans for the PSI.

Research at the Outbreak of a Pandemic – thanking our donors

During the first lockdown in early 2020, an emergency Coronavirus Research Fund was set up to channel the huge amounts of gifts that started pouring in, and to direct them quickly to the research projects that had the biggest chance of mitigating the worst effects of the pandemic.

Oxford’s RECOVERY trial team amongst MRC‘s Outstanding Team Impact prize finalists

The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.

Oxford's Ebola vaccine recommended for deployment against Uganda outbreak

A vaccine developed by the Oxford Vaccine Group’s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from the Jenner Institute (Nuffield Department of Medicine) has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.

$3m Rockefeller Foundation funding to strengthen pandemic surveillance and response innovation co-developed by Oxford biologists

The Rockefeller Foundation has announced $3 million in new funding for (G.h) – a first-of-its-kind, open-source platform for scientific pandemic data. This will enable it to expand its international partnerships and modernize the global effort around coordinated pandemic prevention, surveillance, and response.

PSI hosts GOARN UK Partners Day

The Pandemic Sciences Institute is hosting the UK GOARN partners this week to discuss hot topics such as operational research and rapid response capacity during outbreaks.

Oxford contributes to new UK research consortium to tackle monkeypox

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium – in which the University of Oxford is a key partner – working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.

Oxford University launch new clinical trial to test a treatment for monkeypox

The team behind the world-leading RECOVERY trial of COVID-19 treatments are leading a new study investigating a potential treatment for people who have been diagnosed with monkeypox. The National Institute for Health and Care Research (NIHR) has commissioned and funded the study. The first patients have now been recruited.

Oxford scientists honoured with eight Royal Society Awards

Each year, the Royal Society recognises exceptional research achievements through a series of prestigious medals and prizes named after great scientists of the past. Eight of the 2021-22 awards, announced today, honour Oxford University researchers for their outstanding contributions to science and medicine.


Number-one best-selling authors, nationally-renowned TV presenters, campaigners for justice and equality and the project leader for one of the UK’s most widely used vaccines during the COVID-19 pandemic – all of them and more will be heading to University of East Anglia’s (UEA’s) campus to receive honorary degrees during the University’s graduation celebration this month.

Congratulations to Professor Dame Sarah Gilbert

Professor Dame Sarah Gilbert was given an honorary degree at the University of Hull.

Covid vaccine pioneer Dame Professor Sarah Gilbert receives honorary degree

The University of Bath honoured the life-saving work of vaccinologist Professor Dame Sarah Gilbert, at a graduation ceremony at Bath Abbey on 15 July.

Pandemic Sciences Institute formally launched in Oxford

The University of Oxford’s Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.

Vaccinologist Sarah Gilbert: ‘We need to be better prepared for a new pandemic’

Dame Sarah Gilbert, 60, is a professor of vaccinology at Oxford’s Jenner Institute and author, with Catherine Green, head of Oxford University’s clinical biomanufacturing facility, of Vaxxers – a gripping narrative about developing the AstraZeneca vaccine that is wonderfully accessible and illuminating without dumbing down the science. She lives in Oxford with her husband and grownup triplets.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

The RECOVERY Trial is two years old today

One trial. Over 47,000 participants. Nearly 200 hospital sites, across six countries. Ten results. Four effective COVID-19 treatments. And behind them all, an army of countless researchers, doctors, nurses, statisticians and supporting staff.

Oxford Covid jab gears up for final act: saving the rest of the world


Exactly two years ago Prof Sir Andrew Pollard was starting to panic. “We were just waking up to the reality of Covid-19 and that we would need vaccines for our very survival,” the director of the Oxford Vaccine Group told the Guardian last week

Load More